The U.S. Food and Drug Administration (FDA) endorsed a blood test designed to spot early signs of dozens of cancers despite concerns about how definitive the test’s results may be, the Associated ...

A new study in Cancer Discovery shows that circulating tumor DNA and immune cells drawn from a simple blood sample can ...

A Food and Drug Administration committee backed a cancer blood test called Galleri but was split on how well it works. The test is awaiting a final decision by the FDA.

The harder question is whether finding more cancers through the test actually helps people live longer. If you enjoyed this ...

A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at ...

New tests claim to detect more than 50 types of cancer from a single blood sample, but more research is still needed. Discover more about it. What if you could detect early-stage cancer with a single ...

WASHINGTON — A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle Wednesday as advisers to the U.S. government review how well ...

Astrin Biosciences, a cancer intelligence company transforming how cancer is detected and treated through deep proteomics and AI, today announced that the Certitude™ test, its first-of-its-kind, ...

Cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells, respectively, and they largely matched those ...

A large UK cohort study finds that tracking blood test trends over time, once adjusted for age and sex, discriminates cancer ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...